Takeda Pharmaceutical Company Limit... (TAK)

\$14.02

-0.07 (-0.50%)

 Total Cash Account Receivables Inventories Accounts Payable Capital Expenditure Year A/P 2019 Actual 2020 Actual 2021 Actual 2022 Actual 2023 Actual 2024 Projected 2025 Projected 2026 Projected 2027 Projected 2028 Projected 725,369 653,435.99 1,002,820 874,999.99 553,704 1,195,581.62 1,430,355.63 1,711,231.74 2,047,262.95 2,449,279.94 Total Cash (%) 749,119 784,920.99 812,714.01 724,376.98 681,692.98 1,177,659.49 1,408,914.17 1,685,579.87 2,016,573.87 2,412,564.50 Account Receivables (%) 986,744 759,598.99 753,881.01 853,166.99 986,456.99 1,369,400.41 1,638,306.88 1,960,017.97 2,344,902.84 2,805,366.79 Inventories (%) 212,348 318,816 343,837.99 516,297.01 649,233 589,290.07 705,007.80 843,448.79 1,009,075.17 1,207,225.27 Accounts Payable (%) -134,113.99 -217,710.01 -236,468 -186,037.01 -633,688.99 -398,488.44 -476,738.82 -570,355.09 -682,354.59 -816,347.22 Capital Expenditure (%)

To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.